Article info

Download PDFPDF

Response to: ‘High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?’ by Inanc et al
Free

Authors

  • James Cheng-Chung Wei Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Fang Xiao Zhu Department of Rheumatology and Immunology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China PubMed articlesGoogle scholar articles
  • Jing-Yang Huang Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Fang Xiao Zhu; 1123551518{at}qq.com
View Full Text

Citation

Wei JC, Zhu FX, Huang J
Response to: ‘High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern?’ by Inanc et al

Publication history

  • Received August 24, 2020
  • Accepted August 25, 2020
  • First published September 28, 2020.
Online issue publication 
June 10, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.